Dynamic contrast enhanced magnetic resonance perfusion imaging in high-risk smokers and smoking-related COPD: Correlations with pulmonary function tests and quantitative computed tomography

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 11, Issue 5, 2014, Pages 510-520

  Xia, Yi ^a   Guan, Yu ^a   Fan, Li ^a   Liu, Shi Yuan ^a   Yu, Hong ^a   Zhao, Li Ming ^a   Li, Bing ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Chronic obstructive pulmonary disease; Magnetic resonance imaging; Pulmonary function test; Pulmonary perfusion; Tomography; X ray computed

Indexed keywords

GADOLINIUM PENTETATE; CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONE BEAM COMPUTED TOMOGRAPHY; DISEASE SEVERITY; DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING; EMPHYSEMA; EMPHYSEMA INDEX; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HIGH RISK PATIENT; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RESPIRATORY TRACT PARAMETERS; SMOKING; TOTAL EMPHYSEMA VOLUME; TOTAL LUNG CAPACITY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; LUNG; LUNG VOLUME; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; RADIOGRAPHY; SCINTIGRAPHY; SEVERITY OF ILLNESS INDEX; VASCULARIZATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CONTRAST MEDIA; HUMANS; LUNG; LUNG VOLUME MEASUREMENTS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PERFUSION IMAGING; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SMOKING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84907063627     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2014.948990     Document Type: Article

References (48)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD. 2013. Available from: http://www.goldcopd.org/ (accessed February 2013).
2. Th un MJ, Carter BD, Feskanich D, et al. 50-year trends in smoking-related mortality in the United States. N Engl J Med 2013; 368:351–364.
3. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004; 364:709–721.
4. Szilasi M, Dolinay T, Nemes Z, Strausz J. Pathology of chronic obstructive pulmonary disease. Pathol Oncol Res 2006; 12:52–60.
5. Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J 2008; 32:1371–1385.
6. Wells JM, Washko GR, Han MK, et al. Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med 2012; 367:913–921.
7. Maclay JD, McAllister DA, Rabinovich R, et al. Systemic elastin degradation in chronic obstructive pulmonary disease. Th orax 2012; 67:606–612.
8. Ley-Zaporozhan J, van Beek EJ. Imaging phenotypes of chronic obstructive pulmonary disease. J Magn Reson Imaging 2010; 32: 1340–1352.
9. Matsuoka S, Yamashiro T, Washko GR, et al. Quantitative CT assessment of chronic obstructive pulmonary disease. Radiographics 2010; 30:55–66.
10. Ley-Zaporozhan J, Ley S, Eberhardt R, et al. Visualization of morphological parenchymal changes in emphysema: comparison of diff erent MRI sequences to 3D-HRCT. Eur J Radiol 2010; 73:43–49.
11. Akira M, Toyokawa K, Inoue Y, et al. Quantitative CT in chronic obstructive pulmonary disease: inspiratory and expiratory assessment. AJR Am J Roentgenol. 2009; 192:267–272.
12. Ley-Zaporozhan J, Ley S, Kauczor HU. Morphological and functional imaging in COPD with CT and MRI: present and future. Eur Radiol. 2008; 18:510–521.
13. Kim SS, Seo JB, Lee HY, et al. Chronic obstructive pulmonary disease: lobe-based visual assessment of volumetric CT by Using standard images–comparison with quantitative CT and pulmonary function test in the COPDGene study. Radiology 2013; 266:626–635.
14. Pauls S, Gulkin D, Feuerlein S, et al. Assessment of COPD severity by computed tomography: correlation with lung functional testing. Clin Imag 2010; 34:172–178.
15. Heussel CP, Herth FJ, Kappes J, et al. Fully automatic quantitative assessment of emphysema in computed tomography: comparison with pulmonary function testing and normal values. Eur Radiol 2009; 19:2391–2402.
16. Revel MP, Faivre JB, Remy-Jardin M, et al. Automated lobar quantification of emphysema in patients with severe COPD. Eur Radiol 2008; 18:2723–2730.
17. Pansini V, Remy-Jardin M, Faivre JB, et al. Assessment of lobar perfusion in smokers according to the presence and severity of emphysema: preliminary experience with dual-energy CT angiography. Eur Radiol 2009; 19:2834–2843.
18. Alford SK, van Beek EJ, McLennan G, et al. Heterogeneity of pulmonary perfusion as a mechanistic image-based phenotype in emphysema susceptible smokers. Proc Natl Acad Sci USA 2010; 107:7485–7490.
19. Hopkins SR, Prisk GK. Lung perfusion measured using magnetic resonance imaging: New tools for physiological insights into the pulmonary circulation. J Magn Reson Imaging.2010; 32:1287–1301.
20. Bauman G, Puderbach M, Heimann T, et al. Validation of Fourier decomposition MRI with dynamic contrast-enhanced MRI using visual and automated scoring of pulmonary perfusion in young cystic fibrosis patients. Eur J Radiol 2013; 82(12):2371–2377.
21. Lederlin M, Bauman G, Eichinger M, et al. Functional MRI using Fourier decomposition of lung signal: Reproducibility of ventilation-and perfusion-weighted imaging in healthy volunteers. Eur J Radiol 2013; 82(6):1015–1022.
22. Bauman G, Lützen U, Ullrich M, et al. Pulmonary functional imaging: qualitative comparison of fourier decomposition MR imaging with SPECT/CT in porcine lung. Radiology 2011; 260(2):551–559.
23. Ley S, Ley-Zaporozhan J. Pulmonary perfusion imaging using MRI: clinical application. Insights Imag 2012; 3:61–71.
24. Yilmaz E, Akkoclu A, Degirmenci B, et al. Accuracy and feasibility of dynamic contrast-enhanced 3D MR imaging in the assessment of lung perfusion: comparison with Tc-99 MAA perfusion scintigraphy. Clin Radiol 2005; 60: 905–913.
25. Ohno Y, Hatabu H, Murase K, et al. Quantitative assessment of regional pulmonary perfusion in the entire lung using threedimensional ultrafast dynamic contrast-enhanced magnetic resonance imaging: Preliminary experience in 40 subjects. J Magn Reson Imag 2004; 20:353–365.
26. Fink C, Puderbach M, Bock M, et al. Regional lung perfusion: assessment with partially parallel three-dimensional MR imaging. Radiology 2004; 231:175–184.
27. Ley-Zaporozhan J, Ley S, Eberhardt R, et al. Assessment of the relationship between lung parenchymal destruction and impaired pulmonary perfusion on a lobar level in patients with emphysema. Eur J Radiol. 2007 Jul; 63: 76–83.
28. Fan L, Xia Y, Guan Y, et al. Capability of diff erentiating smokers with normal pulmonary function from COPD patients: a comparison of CT pulmonary volume analysis and MR perfusion imaging. Eur Radiol. 2013 May; 23:1234-1241.
29. Jang YM, Oh YM, Seo JB, et al. Quantitatively assessed dynamic contrast-enhanced magnetic resonance imaging in patients with chronic obstructive pulmonary disease: correlation of perfusion parameters with pulmonary function test and quantitative computed tomography. Invest Radiol. 2008; 43:403–410.
30. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26:948–968.
31. Hansen JE, Sun XG, Wasserman K. Spirometric criteria for airway obstruction: Use percentage of FEV1/FVC ratio below the fifth percentile, not < 70%. Chest 2007; 131:349–55.
32. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932–946.
33. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26:319–338.
34. Bauer RW, Kerl JM, Weber E, et al. Lung perfusion analysis with dual energy CT in patients with suspected pulmonary embolism–influence of window settings on the diagnosis of underlying pathologies of perfusion defects. Eur J Radiol 2011; 80:e476–e482.
35. Fan L, Liu SY, Sun F, Xiao XS. Assessment of pulmonary parenchyma perfusion with FAIR in comparison with DCEMRI–initial results. Eur J Radiol 2009; 70:41–48.
36. Henderson AC, Prisk GK, Levin DL, et al. Characterizing pulmonary blood flow distribution measured using arterial spin labeling. NMR Biomed 2009; 22:1025–1035.
37. Schraml CL, Schwenzer NF, Martirosian P, et al. Non-invasive pulmonary perfusion assessment in young patients with cystic fibrosis using an arterial spin labeling MR technique at 1.5 T. MAGMA. 2012; 25:155–162.
38. Santos S, Peinado VI, Ramirez J, et al. Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167:1250–1256.
39. Peinado VI, Barbera JA, Abate P, et al. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159:1605–1611.
40. Abboud RT, Vimalanathan S. Pathogenesis of COPD. Part I. Th e role of protease-antiprotease imbalance in emphysema. Int J Tuberc Lung Dis 2008; 12:361–336.
41. Hogg JC, Senior RM. Chronic obstructive pulmonary disease-part 2: pathology and biochemistry of emphysema. Th orax 2002; 57:830–834.
42. Th abut G, Dauriat G, Stern JB, et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 2005; 127:1531–1536.
43. Morino S, Toba T, Araki M, et al. Noninvasive assessment of pulmonary emphysema using dynamic contrast-enhanced magnetic resonance imaging. Exp Lung Res 2006; 32:55–67.
44. Zaporozhan J, Ley S, Eberhardt R, et al. Paired inspiratory/expiratory volumetric thin-slice CT scan for emphysema analysis: comparison of diff erent quantitative evaluations and pulmonary function test. Chest 2005; 128:3212–3220.
45. Gevenois PA, De Vuyst P, de Maertelaer V, et al. Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1996; 154:187–192.
46. Gevenois PA, de Maertelaer V, De Vuyst P, et al. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1995; 152:653–657.
47. Aziz ZA, Wells AU, Desai SR, et al. Functional impairment in emphysema: contribution of airway abnormalities and distribution of parenchymal disease. Am J Roentgenol 2005; 185:1509–1515.
48. Cerveri I, Dore R, Corsico A, et al. Assessment of emphysema in COPD: a functional and radiologic study. Chest 2004; 125:1714–1718.